{"filing":{"accession_number":"0001628280-26-043989","cik":"0001411685","ticker":"VTGN","company_name":"Vistagen Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"vtgn-20260616.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/vtgn-20260616.htm"},"events":[{"id":11647,"run_id":10231,"accession_number":"0001628280-26-043989","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Two board members—Margaret FitzPatrick and Dr. Joanne Curley—notified the Company of their decisions not to stand for re-election at the 2026 Annual Meeting. Although they will remain in office until the end of their terms, the disclosure centers on their departure from the Board, which is material to investors assessing governance and board composition at a small-cap biotech company.","company_name":"Vistagen Therapeutics, Inc.","ticker":"VTGN","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8292,"accession_number":"0001628280-26-043989","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Two board members—Margaret FitzPatrick and Dr. Joanne Curley—notified the Company of their decisions not to stand for re-election at the 2026 Annual Meeting. Although they will remain in office until the end of their terms, the disclosure centers on their departure from the Board, which is material to investors assessing governance and board composition at a small-cap biotech company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T21:15:05.629472+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8292,"accession_number":"0001628280-26-043989","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Two board members—Margaret FitzPatrick and Dr. Joanne Curley—notified the Company of their decisions not to stand for re-election at the 2026 Annual Meeting. Although they will remain in office until the end of their terms, the disclosure centers on their departure from the Board, which is material to investors assessing governance and board composition at a small-cap biotech company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T21:15:05.629472+00:00","company_name":"Vistagen Therapeutics, Inc.","ticker":"VTGN","filing_date":"2026-06-17"}]}